Elsevier's 2022 Intravenous Medications
Elsevier - Health Sciences Division (Verlag)
978-0-323-82509-2 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Monographs on more than 400 IV drugs offer an impressive breadth of coverage that goes well beyond any comparable drug reference.
Updated annual publication prevents you from referencing outdated information.
Additional drug monographs are provided on the companion Evolve website.
45-year history of impeccable accuracy reinforces the importance of safe IV drug administration.
Perfect depth of information equips you with everything that is needed for safe administration of IV drugs - nothing more, nothing less.
Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page.
Highlighted Black Box Warnings and relevant content make locating critical information fast and easy.
Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings.
Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
Dilution and dosage charts within monographs provide quick access to essential clinical information.
Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
NEW! Drug monographs for newly approved drugs by the FDA provide you with the most current drug information.
Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications.
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.
General Dilution Charts (inside front cover and facing page)
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs [alphabetical drug monographs]
Back Matter
Appendixes:
A. Recommendations for the Safe Use and Handling of Cytotoxic Drugs
B. FDA Pregnancy Categories
C. U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute Common Terminology Criteria for Adverse Events
D. Information for Patients Receiving Immunosuppressive Agents
E. Recently Approved Drugs
Index
Erscheinungsdatum | 19.07.2021 |
---|---|
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 1650 g |
Themenwelt | Medizin / Pharmazie ► Pflege ► Ausbildung / Prüfung |
ISBN-10 | 0-323-82509-5 / 0323825095 |
ISBN-13 | 978-0-323-82509-2 / 9780323825092 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich